Global Rat Model Market Overview And Scope:
Global Rat Model Market Size was estimated at USD 446.74 million in 2022 and is projected to reach USD 596.93 million by 2028, exhibiting a CAGR of 4.95% during the forecast period.
The Global Rat Model Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Rat Model utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: genOway, Charles River Laboratories International, Inc., Envigo, Covance Inc., Horizon Discovery Group plc, Janvier Labs, Taconic Biosciences, Inc., Biomedical Research Models (Biomere), Transpogen Biopharmaceutical, Inc.
Global Rat Model Market Segmentation
By Type, Rat Model market has been segmented into:Knockout
Outbred
Inbred
Hybrid
Immunodeficient
Conditioned
By Application, Rat Model market has been segmented into:
Oncology
Neurology
Immunology
Toxicology
Other
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Rat Model market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Rat Model market.
Top Key Players Covered in Rat Model market are:
genOway
Charles River Laboratories International
Inc.
Envigo
Covance Inc.
Horizon Discovery Group plc
Janvier Labs
Taconic Biosciences
Inc.
Biomedical Research Models (Biomere)
Transpogen Biopharmaceutical
Inc.
Objective to buy this Report:
1. Rat Model analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Rat Model market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Rat Model Market by Type
5.1 Rat Model Market Overview Snapshot and Growth Engine
5.2 Rat Model Market Overview
5.3 Knockout
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Knockout: Geographic Segmentation
5.4 Outbred
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Outbred: Geographic Segmentation
5.5 Inbred
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Inbred: Geographic Segmentation
5.6 Hybrid
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Hybrid: Geographic Segmentation
5.7 Immunodeficient
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Immunodeficient: Geographic Segmentation
5.8 Conditioned
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Conditioned: Geographic Segmentation
Chapter 6: Rat Model Market by Application
6.1 Rat Model Market Overview Snapshot and Growth Engine
6.2 Rat Model Market Overview
6.3 Oncology
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Oncology: Geographic Segmentation
6.4 Neurology
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Neurology: Geographic Segmentation
6.5 Immunology
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Immunology: Geographic Segmentation
6.6 Toxicology
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Toxicology: Geographic Segmentation
6.7 Other
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Other: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Rat Model Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Rat Model Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Rat Model Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 GENOWAY
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 CHARLES RIVER LABORATORIES INTERNATIONAL
7.4 INC.
7.5 ENVIGO
7.6 COVANCE INC.
7.7 HORIZON DISCOVERY GROUP PLC
7.8 JANVIER LABS
7.9 TACONIC BIOSCIENCES
7.10 INC.
7.11 BIOMEDICAL RESEARCH MODELS (BIOMERE)
7.12 TRANSPOGEN BIOPHARMACEUTICAL
7.13 INC.
Chapter 8: Global Rat Model Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Knockout
8.2.2 Outbred
8.2.3 Inbred
8.2.4 Hybrid
8.2.5 Immunodeficient
8.2.6 Conditioned
8.3 Historic and Forecasted Market Size By Application
8.3.1 Oncology
8.3.2 Neurology
8.3.3 Immunology
8.3.4 Toxicology
8.3.5 Other
Chapter 9: North America Rat Model Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Knockout
9.4.2 Outbred
9.4.3 Inbred
9.4.4 Hybrid
9.4.5 Immunodeficient
9.4.6 Conditioned
9.5 Historic and Forecasted Market Size By Application
9.5.1 Oncology
9.5.2 Neurology
9.5.3 Immunology
9.5.4 Toxicology
9.5.5 Other
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Rat Model Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Knockout
10.4.2 Outbred
10.4.3 Inbred
10.4.4 Hybrid
10.4.5 Immunodeficient
10.4.6 Conditioned
10.5 Historic and Forecasted Market Size By Application
10.5.1 Oncology
10.5.2 Neurology
10.5.3 Immunology
10.5.4 Toxicology
10.5.5 Other
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Rat Model Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Knockout
11.4.2 Outbred
11.4.3 Inbred
11.4.4 Hybrid
11.4.5 Immunodeficient
11.4.6 Conditioned
11.5 Historic and Forecasted Market Size By Application
11.5.1 Oncology
11.5.2 Neurology
11.5.3 Immunology
11.5.4 Toxicology
11.5.5 Other
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Rat Model Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Knockout
12.4.2 Outbred
12.4.3 Inbred
12.4.4 Hybrid
12.4.5 Immunodeficient
12.4.6 Conditioned
12.5 Historic and Forecasted Market Size By Application
12.5.1 Oncology
12.5.2 Neurology
12.5.3 Immunology
12.5.4 Toxicology
12.5.5 Other
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Rat Model Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Knockout
13.4.2 Outbred
13.4.3 Inbred
13.4.4 Hybrid
13.4.5 Immunodeficient
13.4.6 Conditioned
13.5 Historic and Forecasted Market Size By Application
13.5.1 Oncology
13.5.2 Neurology
13.5.3 Immunology
13.5.4 Toxicology
13.5.5 Other
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Rat Model Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Knockout
14.4.2 Outbred
14.4.3 Inbred
14.4.4 Hybrid
14.4.5 Immunodeficient
14.4.6 Conditioned
14.5 Historic and Forecasted Market Size By Application
14.5.1 Oncology
14.5.2 Neurology
14.5.3 Immunology
14.5.4 Toxicology
14.5.5 Other
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Rat Model Scope:
|
Report Data
|
Rat Model Market
|
|
Rat Model Market Size in 2025
|
USD XX million
|
|
Rat Model CAGR 2025 - 2032
|
XX%
|
|
Rat Model Base Year
|
2024
|
|
Rat Model Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
genOway, Charles River Laboratories International, Inc., Envigo, Covance Inc., Horizon Discovery Group plc, Janvier Labs, Taconic Biosciences, Inc., Biomedical Research Models (Biomere), Transpogen Biopharmaceutical, Inc..
|
|
Key Segments
|
By Type
Knockout
Outbred
Inbred
Hybrid
Immunodeficient
Conditioned
By Applications
Oncology
Neurology
Immunology
Toxicology
Other
|
